Semaglutide may lower risk of serious complications in high-risk diabetes
A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and peripheral artery disease (PAD), particularly those at highest risk of amputation. Today’s News Updated on July 3, 2026 at 8:00 a.m. PST ...